Kaken Pharmaceutical (4521.TSE) Q1 2026 Earnings

Feb 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-139
-85
-30
25

Details

Expected EPS
25
Actual EPS
11
Surprise EPS
-14
Surprise Percent
-56.8%

Description

⁨Kaken Pharmaceutical⁩ (⁦4521.TSE⁩) has reported earnings of ⁦11⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts